ARSD 20:51:14:07. Granted waiver -- Annual review -- Adverse issue -- Suspension and review

The State Board of Pharmacy shall review each waiver at least annually. Upon notification by the State Board of Pharmacy, the board shall investigate the reported issue. Upon investigation, if the board determines the requirements of § 20:51:14:05 are not upheld, the board shall notify the licensee or pharmacist-in-charge, in writing, that the waiver is suspended pending full review by the board at the next available regularly scheduled meeting. During the suspension, the licensee or pharmacist-in-charge must ensure compliance with all rules in this article, regardless of any rule that was waived.